AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COCHLEAR LTD

133.920

-2.180-1.60%

Volume:9.70M

Turnover:1.30B

Market Cap:8.76B

PE:59.57

High:135.670

Open:135.260

Low:132.330

Close:136.100

52wk High:297.775

52wk Low:88.740

Shares:65.40M

Float Shares:65.14M

Volume Ratio:22.24

T/O Rate:14.89%

Dividend:4.30

Dividend Rate:3.21%

EPS(TTM):2.248

EPS(LYR):2.248

ROE:7.98%

ROA:9.71%

PB:5.03

PE(LYR):59.57

Loading ...

Overview Company News Filings

Australian Shares End Lower as Miners Drag

Cochlear, Sonic Healthcare Fall on MSCI Australia Index Exit

Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value

Simply Wall St.

Cochlear (ASX:COH) Cut Its Dividend After Full Year Results, Is The Rebound Already Priced In?

Simply Wall St.

Lynas Rare Earths Stock And 2 Australian Value Picks Trading Below Fair Value

Simply Wall St.

Should Cochlear’s Weaker Profit, Lower Dividend and Soft Outlook Require Action From Cochlear (ASX:COH) Investors?

Simply Wall St.

U.S. Payer Constraints Limit Cochlear's Near-Term Opportunities

ASX Stocks Estimated To Be Trading Below Fair Value In August 2026

Simply Wall St.

Cochlear (ASX:COH) Shares Climb As Margins Crumple Under One Off Losses

Simply Wall St.

Cochlear Beat Fiscal 2026 Underlying NPAT Estimates Due to Reduction in Expenses, Jarden Says

MT Newswires Live

Australia's Cochlear Set for Biggest Gain in More than a Year After FY Earnings Beat

Cochlear's Profit Growth Guidance Looks Cost-Driven

Cochlear Slashes Dividend as Annual Profit Drops 18%

Cochlear Fiscal 2026 Underlying Earnings Down, Revenue Up

MT Newswires Live

Cochlear Sees Net Profit Margin to Return to 18% over Medium Term

Cochlear Posts FY Sales of AUD 2,343.4 Million

Cochlear Limited - Net Profit Margin is Expected to Return to 18% over the Medium Term.

THOMSON REUTERS

Cochlear Limited - Expecting Low Single-Digit Constant Currency Sales Revenue Growth and Underlying Net Profit of A$330-350 Million in FY27

THOMSON REUTERS

Cochlear Limited - Sees FY27 Capital Expenditure of A$100-A$110 Million

THOMSON REUTERS

Cochlear Limited - Further Restructuring Costs are Expected in FY27

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/COH.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":133.92,"timestamp":1788156720000,"preClose":136.1,"halted":0,"volume":9698531,"delay":0,"changeRate":-0.016017634092579038,"nameEN":"COCHLEAR LTD","floatShares":65138365,"shares":65398462,"eps":2.248,"marketStatus":"Not Yet Opened","change":-2.18,"latestTime":"08-31 16:12:00 AEST","open":135.26,"high":135.67,"low":132.33,"amount":1298875575,"amplitude":0.024541,"askPrice":135,"askSize":20,"bidPrice":133.7,"bidSize":24,"shortable":3,"etf":0,"ttmEps":2.248,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":136.1,"dividendRate":0.032115,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":22.24299,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"COH.AU","preClose":136.1,"auctionPrice":133.91,"auctionVolume":5737806,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156606438}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138365,"roa":"9.71%","roe":"7.98%","lyrEps":2.248,"volumeRatio":22.24299,"shares":65398462,"dividePrice":4.3008,"high":135.67,"amplitude":0.024541,"preClose":136.1,"low":132.33,"week52Low":88.74,"pbRate":"5.03","psRate":"3.73","week52High":297.775,"institutionHeld":0,"latestPrice":133.92,"committee":0.090909,"eps":2.248,"divideRate":0.032115,"volume":9698531,"delay":0,"ttmEps":2.248,"open":135.26,"prevYearClose":257.41,"prevWeekClose":136.1,"prevMonthClose":119.94,"prevQuarterClose":121.75,"fiveDayClose":135.77,"twentyDayClose":120.74,"sixtyDayClose":100.45,"dividendPayoutRate":1.9096682506550604,"dividendGrowthYears":5,"dividendGrowthRate":0.0117647058823529,"fiveYearAvgDividendRate":0.018048554743331537},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"COH.AU","amount":1.3,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-22","defaultRemindTime":1789948800000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-14","payableDate":"2026-09-22","currency":"AUD","dateTimestamp":1789912800000,"payDate":"2026-10-14"},{"date":"2026-08-18","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-19","symbol":"COH.AU","amount":2.15,"announcedDate":"2026-02-12","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-20","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-13","payableDate":"2026-03-20","currency":"AUD","dateTimestamp":1773838800000,"payDate":"2026-04-13"},{"date":"2026-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770937200000,"name":null,"time":"","dateTimestamp":1770901200000,"actualEps":null},{"date":"2025-09-18","symbol":"COH.AU","amount":2.15,"announcedDate":"2025-08-15","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-19","defaultRemindTime":1758153600000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-13","payableDate":"2025-09-19","currency":"AUD","dateTimestamp":1758117600000,"payDate":"2025-10-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663020410","title":"Australian Shares End Lower as Miners Drag","url":"https://stock-news.laohu8.com/highlight/detail?id=2663020410","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663020410?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:17","pubTimestamp":1788160620,"startTime":"0","endTime":"0","summary":"Australian shares end lower as miners dragAug 31 (Reuters)-Australian shares slid on Monday, dragged by miners, outweighing gains in financials as investors digested Federal Reserve Chair Kevin Warsh'","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S0G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3M56506.USD","BK7124","LU0345781412.USD","SHL.AU","LU1078025761.USD","LU0161305163.EUR","LU1064927863.SGD","LU0788109121.HKD","LU1130305938.SGD","LU0955623706.USD","COH.AU","LU0345780950.USD","LU0955669360.SGD","LU0171293334.USD","BHP.AU","LU0572940350.SGD","LU1309081286.SGD","LU0266512473.USD","LU0572939691.SGD","LU0955648018.USD","LU0505663152.USD","LU2463526074.USD","LU1302929846.USD","LU0011963245.USD","LU0345777147.USD","LU1023059493.AUD","BK7507","RIO.UK","LU0898667661.SGD","LU0971552673.USD","SG9999001143.SGD","LU0264606111.USD","LU0075056555.USD","LU0345777659.USD","LU0630314457.HKD","LU0266512127.USD","RIO.AU","LU0456854461.SGD","BK7095","LU1430597077.USD","IE00BQJZX424.USD","LU0971552830.HKD","LU0612318971.USD","LU0330918003.SGD","LU0612318385.USD","LU1481600234.SGD","IE0034235071.USD","LU1046248800.SGD","LU0654597011.USD","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022973","title":"Cochlear, Sonic Healthcare Fall on MSCI Australia Index Exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663022973?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:52","pubTimestamp":1788155577,"startTime":"0","endTime":"0","summary":"BUZZ-Cochlear, Sonic Healthcare fall on MSCI Australia Index exit** Hearing implants maker CochlearCOH.AXfalls as much as 2.8% and diagnostics services provider Sonic HealthcareSHL.AXlose as much as 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S0EX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHL.AU","BK7124","BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663833045","title":"Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2663833045","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663833045?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:29","pubTimestamp":1788046160,"startTime":"0","endTime":"0","summary":"With central banks focused on inflation that has not meaningfully slowed, investors are paying closer attention to cash flows and valuation discipline. When policy makers keep rates in focus, solid cash generation can matter more than short term sentiment swings. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that combine discounted SWS DCF valuations with attractive cash flow potential for patient, value-oriented investors.\nThe three stocks in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-stock-and-two-asx-cash-flow-picks-trading-below-fai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-stock-and-two-asx-cash-flow-picks-trading-below-fai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX.AU","BK7007","COH.AU","TACU","BK4588","TLX","BK7067","BK4139","SPHQ","CDIG","BK7095","LYC.AU","BK7507","BK4585","TSPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662213711","title":"Cochlear (ASX:COH) Cut Its Dividend After Full Year Results, Is The Rebound Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662213711","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662213711?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:26","pubTimestamp":1787743600,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) came into focus on 17 August 2026 after issuing full year 2026 results, cutting its ordinary dividend and guiding to low single digit constant currency sales revenue growth for fiscal 2027.\nCochlear's recent update comes after a sharp reset in sentiment, with the share price at A$137.71, a 30 day share price return of 20.27% and a 90 day share price return of 41.39%. However, the year to date share price return is down 47.24% and the 1 year total shareholder return is down...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-cut-its-dividend-after-full-year-results-is","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-cut-its-dividend-after-full-year-results-is","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","DCF","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661230167","title":"Lynas Rare Earths Stock And 2 Australian Value Picks Trading Below Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2661230167","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661230167?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:27","pubTimestamp":1787257675,"startTime":"0","endTime":"0","summary":"Central banks are wrestling with inflation and interest rate questions, yet the PBoC is holding its loan prime rates at record lows. That means pockets of support still exist while many investors remain cautious. This disconnect can leave high quality undervalued stocks mispriced. In this article you will see three stocks from our High Quality Undervalued Stocks screener that combine strong fundamentals with attractive entry points.\nThe three stocks below are just a starting sample from this...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/lynas-rare-earths-stock-and-2-australian-value-picks-trading","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/lynas-rare-earths-stock-and-2-australian-value-picks-trading","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LYC.AU","IIGF.AU","BBOZ.AU","GIVE.AU","BK7015","IOZ.AU","SLF.AU","XAO.AU","IISV.AU","BK7095","VAS.AU","XKO.AU","COH.AU","GEAR.AU","VAP.AU","BK4585","ZYAU.AU","EIGA.AU","SETM","BK4588","QFN.AU","BK7007","SLC.AU","DACE.AU","SPHQ","BK7507","E200.AU","BEAR.AU","QRE.AU","XJO.AU","STW.AU","IMLC.AU","OZF.AU","OZR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660405288","title":"Should Cochlear’s Weaker Profit, Lower Dividend and Soft Outlook Require Action From Cochlear (ASX:COH) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660405288","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660405288?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:24","pubTimestamp":1787192679,"startTime":"0","endTime":"0","summary":"Cochlear Limited recently reported its full-year 2026 results, with sales of A$2,347.6 million, net income of A$147.3 million, and a lower ordinary dividend of A$1.30 per security for the six months to June 30, 2026.\nAlongside modest revenue growth, the sharp reduction in earnings per share and guidance for only low single-digit constant-currency sales growth in fiscal 2027 raises questions about the balance between Cochlear’s innovation spending and its profitability and payout...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/should-cochlears-weaker-profit-lower-dividend-and-soft-outlo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/should-cochlears-weaker-profit-lower-dividend-and-soft-outlo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VTHR","COH.AU","AIPO","DECU","FEBU","AGIX","PMDE","BK7007","GXDW","RGLO","VOTE","CHAT","QTOC","VGFPF","BK4211","ARTY","ISBC","JOYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490504","title":"U.S. Payer Constraints Limit Cochlear's Near-Term Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490504?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:31","pubTimestamp":1787092260,"startTime":"0","endTime":"0","summary":"2231 GMT - Cochlear's opportunities for near-term growth are limited by persistent payer constraints, Jefferies analysts warn. They tell clients in a note they are seeing an increase in prior authorization rejections in U.S. healthcare, which the Australian hearing-implant maker will have to contend with. Higher out-of-pocket costs could lead to delays in higher-priced procedures such as cochlear implants, they warn. The analysts also point to external analysis suggesting that insurers denied between 12% and 18% of U.S. standard prior authorization requests in 2025. They raise their target price 13% to 144.75 Australian dollars, but stay neutral on the stock. Shares are at A$141.20 ahead of the open.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497250","title":"ASX Stocks Estimated To Be Trading Below Fair Value In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497250","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497250?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:04","pubTimestamp":1787079872,"startTime":"0","endTime":"0","summary":"As the Australian market grapples with the implications of rising oil prices and their potential inflation impacts, investors are increasingly looking for opportunities within sectors that may be trading below their intrinsic value. In such a climate, identifying undervalued stocks can be particularly advantageous, as these investments often offer significant potential for growth when broader market conditions stabilize.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-augus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-augus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","BK7015","BK7503","FDV.AU","BK7055","SLC.AU","BK7007","BK4588","SPHQ","BK7104","NWH.AU","BK7126","MSB.AU","COH.AU","BK7508","BK7067","BK7062","NGI.AU","PNV.AU","NXL.AU","BK4585","SYL.AU","DECU","XRO.AU","BK7501","PMDE","BK7002","BK7016","GMD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469168","title":"Cochlear (ASX:COH) Shares Climb As Margins Crumple Under One Off Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469168","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469168?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:20","pubTimestamp":1787044843,"startTime":"0","endTime":"0","summary":"Cochlear stock has been on a tear, up about 49% over the past three months to A$141.20, yet the latest result landed with a thud on the income line. The headline is simple: revenue held above A$2.3b, but a large one off loss over the past year dragged reported earnings into the red and compressed net margins to 6.3% from 16.6%.\nShort term traders are reacting to that squeeze. Long term holders are weighing a P/E of 62.7x against earnings forecasts that still point to faster profit growth than...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-shares-climb-as-margins-crumple-under-one-of","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/cochlear-asxcoh-shares-climb-as-margins-crumple-under-one-of","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","COH.AU","FEBU","PMDE","VOTE","JOYT","VGFPF","RGLO","BK7007","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660545669","title":"Cochlear Beat Fiscal 2026 Underlying NPAT Estimates Due to Reduction in Expenses, Jarden Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660545669","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660545669?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:24","pubTimestamp":1787019853,"startTime":"0","endTime":"0","summary":"Cochlear's  fiscal 2026 underlying net profit after tax  beat consensus estimates by over 4% largely due to a AU$20 million reduction in selling, general, and administrative expenses in the latter half of the year, Jarden said in a Tuesday note.The revenue mix weighed on the company's gross margin, which at 70.6% came in well below guidance of 72%. This was impacted by lower-than-expected developed market revenue and increased low-tier sales in China, the equity research firm said.\"All up, the quality of [fiscal 2026] is worse than anticipated due largely to mix,\" it said.However, the company's fiscal 2027 guidance for underlying NPAT of AU$330 million to AU$350 million is in line with consensus forecasts, with further restructuring costs expected in the current fiscal year.\"We expect this stock should trade favorably on this outlook,\" Jarden said. It maintained a neutral rating on Cochlear with a target price of AU$169.Cochlear shares gained 6% in recent Tuesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660539034","title":"Australia's Cochlear Set for Biggest Gain in More than a Year After FY Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2660539034","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660539034?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:02","pubTimestamp":1787014921,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cochlear set for biggest gain in more than a year after FY earnings beat** Shares of Australia's CochlearCOH.AXclimb as much as 5.9% to A$139.000, heading for their biggest pct rise s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F011:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660746458","title":"Cochlear's Profit Growth Guidance Looks Cost-Driven","url":"https://stock-news.laohu8.com/highlight/detail?id=2660746458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660746458?lang=en_us&edition=fundamental","pubTime":"2026-08-18 08:34","pubTimestamp":1787013240,"startTime":"0","endTime":"0","summary":"0034 GMT - Cochlear's expectation of FY 2027 profit growth appears to be driven by operating costs rather than sales, Jarden analysts observe. They tell clients in a note that the hearing-implant maker's guidance for 5.5% net profit growth at the range midpoint comes despite its expectation that sales revenue will only grow by a percentage in the low single digits. They tell clients in a note that the profit guidance, which is in line with analysts' expectations, is supported by a slight on-year decline in operating costs. They think that the quality of the FY 2026 result was worse than anticipated, but see the FY 2027 outlook as positive. Jarden has a last-published neutral rating on the stock and a target price of 169.00 Australian dollars. Shares are up 5.0% at A$137.80.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660430916","title":"Cochlear Slashes Dividend as Annual Profit Drops 18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660430916","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660430916?lang=en_us&edition=fundamental","pubTime":"2026-08-18 07:12","pubTimestamp":1787008320,"startTime":"0","endTime":"0","summary":"SYDNEY--Cochlear slashed its dividend after an 18% fall in annual profit, four months after a profit warning that sparked the biggest-ever drop in the hearing-implant maker's share price.Cochlear, whi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cochlear Slashes Dividend as Annual Profit Drops 18%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660240437","title":"Cochlear Fiscal 2026 Underlying Earnings Down, Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660240437","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660240437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:13","pubTimestamp":1787004807,"startTime":"0","endTime":"0","summary":"Cochlear  logged AU$4.929 in underlying basic earnings per share for the fiscal 2026, compared with AU$6.334 a year ago, a Tuesday filing showed.Analysts polled by FactSet expected earnings of AU$4.72For the 12 months ended June 30, revenue was AU$2.35 billion versus AU$2.34 billion previously, the Australia-listed medical device company added.Analysts surveyed by FactSet expected AU$2.33 billion.The board declared a final dividend of AU$1.30 per share, down from AU$2.15 a year earlier, payable Oct. 14 to shareholders on record as of Sept. 22.The company expects fiscal 2027 low single-digit constant-currency sales revenue growth and underlying net profit of AU$330 million to AU$350 million. Gross margin is expected at 70% to 71%, while net profit margin is expected to return to 18% over the medium term.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660921437","title":"Cochlear Sees Net Profit Margin to Return to 18% over Medium Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2660921437","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660921437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:46","pubTimestamp":1787003161,"startTime":"0","endTime":"0","summary":"Aug 18 (Reuters) - Cochlear Limited::*EXPECTING LOW SINGLE-DIGIT CONSTANT CURRENCY SALES REVENUE GROWTH AND UNDERLYING NET PROFIT OF A$330-350 MILLION IN FY27*NET PROFIT MARGIN IS EXPECTED TO RETURN T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nRSD2QXdWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660379364","title":"Cochlear Posts FY Sales of AUD 2,343.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660379364","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660379364?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:41","pubTimestamp":1787002883,"startTime":"0","endTime":"0","summary":"Aug 18 (Reuters) - Cochlear:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 17-AUG-202621:14:00.073 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nRSD5BNsXw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437662","title":"Cochlear Limited - Net Profit Margin is Expected to Return to 18% over the Medium Term.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437662?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:31","pubTimestamp":1787002309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0YW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437635","title":"Cochlear Limited - Expecting Low Single-Digit Constant Currency Sales Revenue Growth and Underlying Net Profit of A$330-350 Million in FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437635?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:31","pubTimestamp":1787002309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660376674","title":"Cochlear Limited - Sees FY27 Capital Expenditure of A$100-A$110 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660376674","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660376674?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:31","pubTimestamp":1787002309,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0YW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660143766","title":"Cochlear Limited - Further Restructuring Costs are Expected in FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2660143766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660143766?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:31","pubTimestamp":1787002309,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0YW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":107,"code":"91000000","status":"200"}]}}